--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K
-------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
-------------
Date of report (Date of earliest event reported): November 3, 2003
TUTOGEN MEDICAL, INC.
(Exact name of registrant as specified in its charter)
FLORIDA 01-16128 59-3100165
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) file number) Identification No.)
1130 MCBRIDE AVENUE
3RD FLOOR
WEST PATERSON, NEW JERSEY 07424
(Address of principal executive offices) (Zip Code)
(973) 785-0004
(Registrant's telephone number, including area code)
NOT APPLICABLE
(Former name or former address, if changed since last report)
--------------------------------------------------------------------------------
ITEM 5. OTHER EVENTS.
On November 3, 2003, Tutogen Medical, Inc. ("the Company") issued a
Press release (which is attached hereto as Exhibit 99.1) announcing that the
Company has entered into a non-binding letter agreement with an unaffiliated
private equity firm proposing to acquire all of the outstanding shares of common
stock of the Company for $6.00 per share in cash, subject to a due diligence
review and the execution of definitive transaction documents.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(C) EXHIBITS.
99.1 Text of Press release issued by Tutogen Medical, Inc., dated
November 3, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
TUTOGEN MEDICAL, INC.
By: /s/ George Lombardi
----------------------------
George Lombardi
Chief Financial Officer
Dated: November 3, 2003
EXHIBIT INDEX
Exhibit
Number Description
------ -----------
99.1 Text of Press release issued by Tutogen Medical, Inc., dated
November 3, 2003.